Our work is entirely funded by private donations – we receive no money from government. Your money will help us continue funding research into vitiligo and supporting people affected by the condition.
FAQ
Extracts of the tropical fern Polypodium leucotomos appear to have beneficial properties for the vitiligious skin. Polypodium leucotomos (also classified as Polypodium aureum) and Polypodium decumanum (also classified as Phlebodium decumanum) are indigenous to the Honduran rainforests but also can be found throughout the South American tropics and in parts of Latin America and the Caribbean. In Brazil, the common name is 'samambaia'; in Mexico and other Spanish-speaking tropical countries, the plant is known as 'calaguala.'
Indigenous people of the rainforest have long used the plants to treat and alleviate symptoms of autoimmune disorders and inflammatory conditions, including vitiligo, psoriasis, arthritis, lupus, kidney problems and malignant tumors. Its use as a tea for blood cleansing began with the Mayans, and continues today in Honduran culture.
Several clinical studies have demonstrated a significant effect of the fern on facial vitiligo. Participants were given 250 mg tablets thrice-times daily in combination with NB-UVB, twice-weekly for six months. Patients attending >80 percent of required phototherapy sessions reported a substantial repigmentation in the head and neck area, and no significant differences were seen in the other body areas. Repigmentation was more pronounced in people with lighter skin – Fitzpatrick types II and III.
The mechanism of action of Polipodium leucotomas extract is fairly complex and can be summarized into the following main points:
- Acts as a scavenger to mop up free radicals and reactive oxygen species
- Inhibits the depletion of Langerhans cells
- Reduces the number of sunburn cells
- Protects DNA by inhibiting the formation of cyclobutane pyrimidine dimers (cancer-causing cells) induced by UVB radiation.
Polypodium leucotomos extract is marketed as a dietary supplement in many countries under different names, such as Heliocare®, Calaguala and others.
The recommended dose of i.e. of Calaguala 500 mg capsules containing 100% pure Calaguala rhizome (Polypodium leucotomos) and Samambaia rhizome and leaf (Polypodium decumanum) is 2-3 capsules twice daily. It is rapidly absorbed and provides early protection that lasts few hours against the initial signs of sunburn - skin redness, or erythema reaction. However, its photoprotective effect extends beyond just decreasing the erythema reaction. The antioxidant properties of orally administered P. leucotomas extract work at protecting the skin at a deeper cellular level which is not achieved with topically applied antioxidants.
To date, Polipodium leucotomos has demonstrated an exceptional safety profile, but it has not been clinically tested in patients less than 18 years and in pregnant or breastfeeding women.
FAQOther Questions
- I have vitiligo: will my children have vitiligo, too?
Children born to parents who both have the disorder are more likely to develop vitiligo. However, most children will not get vitiligo even if one parent has it. In children with...
- Is it possible to stop the progression of vitiligo?
It is true that vitiligo progression could be stopped in 4 out of 5 cases by the use of potent systemic corticosteroids - that is, oral medications. However, systemic corticost...
- What's the status with official recognition of World Vitiligo Day?
In 2016, the United Nations marked World Vitiligo Day in its International Calendar of Disability Events. However, it was removed in 2019 when the calendar was streamlined to 'M...
Though it is not always easy to treat vitiligo, there is much to be gained by clearly understanding the diagnosis, the future implications, treatment options and their outcomes.
Many people deal with vitiligo while remaining in the public eye, maintaining a positive outlook, and having a successful career.
Copyright (C) Bodolóczki JúliaBy taking a little time to fill in the anonymous questionnaire, you can help researchers better understand and fight vitiligo.